ReviewCardiovascular & hematological agents in medicinal chemistry2013

Ibrutinib: a new frontier in the treatment of chronic lymphocytic leukemia by Bruton's tyrosine kinase inhibition.

Ajoy Lawrence Dias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.